Eli Lilly Price to Book Ratio 2006-2019 | LLY

Historical price to book ratio values for Eli Lilly (LLY) over the last 10 years. The current price to book ratio for Eli Lilly as of September 17, 2019 is 37.21.
Eli Lilly Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2019-09-18 112.72 38.08
2019-06-30 110.79 $2.96 37.43
2019-03-31 129.76 $2.64 49.11
2018-12-31 115.11 $10.32 11.15
2018-09-30 106.20 $13.36 7.95
2018-06-30 83.98 $10.82 7.76
2018-03-31 75.62 $13.44 5.63
2017-12-31 81.96 $10.61 7.73
2017-09-30 82.48 $13.59 6.07
2017-06-30 78.85 $12.87 6.13
2017-03-31 80.07 $12.78 6.26
2016-12-31 69.55 $12.79 5.44
2016-09-30 75.41 $14.15 5.33
2016-06-30 73.52 $13.28 5.54
2016-03-31 66.78 $13.62 4.90
2015-12-31 77.60 $13.20 5.88
2015-09-30 76.60 $13.75 5.57
2015-06-30 75.96 $13.27 5.73
2015-03-31 65.65 $13.47 4.87
2014-12-31 61.90 $13.86 4.47
2014-09-30 57.76 $15.88 3.64
2014-06-30 54.93 $16.11 3.41
2014-03-31 51.59 $16.39 3.15
2013-12-31 44.29 $15.80 2.80
2013-09-30 43.29 $15.00 2.89
2013-06-30 41.88 $13.52 3.10
2013-03-31 47.99 $13.28 3.62
2012-12-31 41.30 $12.92 3.20
2012-09-30 39.29 $13.84 2.84
2012-06-30 35.16 $12.33 2.85
2012-03-31 32.61 $12.77 2.55
2011-12-31 33.24 $11.69 2.84
2011-09-30 29.18 $13.01 2.24
2011-06-30 29.22 $12.33 2.37
2011-03-31 27.04 $12.04 2.25
2010-12-31 26.56 $10.76 2.47
2010-09-30 27.31 $10.76 2.54
2010-06-30 24.71 $8.88 2.78
2010-03-31 26.35 $9.07 2.90
2009-12-31 25.61 $8.29 3.09
2009-09-30 23.36 $8.62 2.71
2009-06-30 24.14 $7.45 3.24
2009-03-31 22.96 $6.72 3.42
2008-12-31 27.31 $5.93 4.61
2008-09-30 29.43 $12.09 2.44
2008-06-30 30.56 $12.96 2.36
2008-03-31 33.82 $13.11 2.58
2007-12-31 34.68 $11.90 2.91
2007-09-30 36.68 $11.41 3.21
2007-06-30 35.74 $10.19 3.51
2007-03-31 34.10 $10.17 3.35
2006-12-31 32.82 $9.70 3.38
2006-09-30 35.64 $11.54 3.09
2006-06-30 34.31 $10.55 3.25
2006-03-31 34.06 $10.35 3.29
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $106.323B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $341.878B 14.89
Roche Holding AG (RHHBY) Switzerland $235.862B 0.00
Merck (MRK) United States $210.028B 17.27
Pfizer (PFE) United States $203.709B 12.00
Novartis AG (NVS) Switzerland $197.630B 16.99
Novo Nordisk (NVO) Denmark $117.169B 20.70
AstraZeneca (AZN) United Kingdom $111.536B 21.58
Sanofi (SNY) France $109.180B 13.41
AbbVie (ABBV) United States $104.351B 8.36
GlaxoSmithKline (GSK) United Kingdom $101.265B 12.73
Bristol-Myers Squibb (BMY) United States $80.921B 11.48
Bayer (BAYRY) Germany $69.755B 10.16
H Lundbeck (HLUYY) Denmark $6.896B 9.95